Market Cap

Australis Capital, Inc. Market Capitalization:

$48,752

USD as of Jan. 1, 2024

business Australis Capital, Inc. Company Profile

Australis Capital, Inc. Main Stock Listing

OTC: AUSAF

Market Capitalization History of Australis Capital, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Australis Capital, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $48,752 -99.12%
Jan. 1, 2023 $5.6 M -69.90%
Jan. 1, 2022 $18.5 M -67.61%
Jan. 1, 2021 $57.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Australis Capital, Inc. Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

Australis Capital, Inc. has the following listings and related stock indices.


Stock: OTC: AUSAF

Stock: CSE: AUSA

Stock: FSX: AC4

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.